Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

302.00SEK
8:20am EDT
Change (% chg)

-1.50kr (-0.49%)
Prev Close
303.50kr
Open
304.00kr
Day's High
304.50kr
Day's Low
300.00kr
Volume
4,340
Avg. Vol
17,471
52-wk High
369.50kr
52-wk Low
243.50kr

Chart for

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.91
Market Cap(Mil.): kr5,036.82
Shares Outstanding(Mil.): 16.60
Dividend: 3.16
Yield (%): 2.47

Financials

  Industry Sector
P/E (TTM): -- 22.75 15.95
EPS (TTM): -- -- --
ROI: -- 12.41 15.19
ROE: -- 15.81 13.87

BRIEF-BioGaia Q2 op profit rose to SEK 60 mln

* Q2 net sales amounted to SEK 156.0 million (136.0), an increase of 15% (excluding foreign exchange effects, 10%).

Aug 18 2017

BRIEF-Biogaia Q1 operating profit increases to SEK 56 mln

* Q1 net sales amounted to SEK 141.1 million (133.9), an increase of SEK 7.2 million (5 pct)

May 03 2017

Earnings vs. Estimates